SE421615B - Sett att framstella nya tiazolderivat - Google Patents

Sett att framstella nya tiazolderivat

Info

Publication number
SE421615B
SE421615B SE7311181A SE7311181A SE421615B SE 421615 B SE421615 B SE 421615B SE 7311181 A SE7311181 A SE 7311181A SE 7311181 A SE7311181 A SE 7311181A SE 421615 B SE421615 B SE 421615B
Authority
SE
Sweden
Prior art keywords
tiazle
want
derivatives
make new
new
Prior art date
Application number
SE7311181A
Other languages
English (en)
Swedish (sv)
Inventor
T Hibino
Y Suzuki
S Okano
Y Hara
E Sato
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP47082574A external-priority patent/JPS5238559B2/ja
Priority claimed from JP48039354A external-priority patent/JPS49125359A/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SE421615B publication Critical patent/SE421615B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7311181A 1972-08-17 1973-08-16 Sett att framstella nya tiazolderivat SE421615B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP47082574A JPS5238559B2 (OSRAM) 1972-08-17 1972-08-17
JP48039354A JPS49125359A (OSRAM) 1973-04-05 1973-04-05
ZA00741280A ZA741280B (en) 1972-08-17 1974-02-26 Thiazole derivatives

Publications (1)

Publication Number Publication Date
SE421615B true SE421615B (sv) 1982-01-18

Family

ID=27290112

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7311181A SE421615B (sv) 1972-08-17 1973-08-16 Sett att framstella nya tiazolderivat

Country Status (10)

Country Link
US (1) US3932400A (OSRAM)
CA (1) CA991640A (OSRAM)
CH (1) CH581640A5 (OSRAM)
DE (1) DE2341753C2 (OSRAM)
DK (1) DK149893C (OSRAM)
FR (1) FR2196162B1 (OSRAM)
GB (1) GB1435139A (OSRAM)
NL (1) NL179733C (OSRAM)
SE (1) SE421615B (OSRAM)
ZA (1) ZA741280B (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
US4119718A (en) * 1977-05-02 1978-10-10 Merck & Co., Inc. 3-Amino-2-oxy-propoxy-substituted isothiazoles
US4260609A (en) * 1977-06-01 1981-04-07 Merck & Co., Inc. Di- and tri- substituted thiazoles
US4259341A (en) * 1977-06-01 1981-03-31 Merck & Co., Inc. Di- and tri-substituted thiazoles
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
BR0313593A (pt) 2002-08-19 2005-07-12 Pfizer Prod Inc Terapia de combinação para doenças hiperproliferativas
CN1812983A (zh) * 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
CA2590533C (en) * 2004-11-23 2010-09-07 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
SG166829A1 (en) * 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US20090226420A1 (en) * 2005-11-10 2009-09-10 Elizabeth Hauser Methods of Determining the Risk of Developing Coronary Artery Disease
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
AU2007207743B2 (en) * 2006-01-18 2010-07-08 Amgen Inc. Thiazole compounds as protein kinase B (PKB) inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
CL2007002044A1 (es) * 2006-07-14 2008-06-13 Ranbaxy Lab Ltd Polimorfo cristalino de la sal hemicalcica del acido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3,5-dihidroxiheptanoico; composicion farmaceutica; y uso para el tratamiento de la diabetes, enf
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2009011871A2 (en) * 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of pkb
CA2909442A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104530033B (zh) * 2014-12-26 2017-07-07 江西百神药业股份有限公司 一种盐酸阿罗洛尔的制备工艺新方法
CN105646472A (zh) * 2016-02-29 2016-06-08 山东齐都药业有限公司 一种盐酸阿罗洛尔的制备方法
HUE069590T2 (hu) 2019-01-18 2025-03-28 Astrazeneca Ab PCSK9-gátló 6'-[[(1s,3s)-3-[[5-(difluormetoxi)-2-pirimidinil]amino]ciklopentil]amino][1(2h ),3'-bipiridin]-2-on és alkalmazására szolgáló eljárások

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA599475A (en) * 1960-06-07 W. Harman Marion Aminoethylthiazoles
US2221147A (en) * 1938-11-18 1940-11-12 Goodrich Co B F Preparation of aminated esters of sulphydryl compounds
US3228952A (en) * 1962-06-27 1966-01-11 Dow Chemical Co Thiazole thioethers
US3158623A (en) * 1963-03-01 1964-11-24 Abbott Lab 5-nitro-2-furylthioamide
BE790569A (fr) * 1971-10-27 1973-04-26 Syntex Corp Agents cardiovasculaires a base de thiazoles

Also Published As

Publication number Publication date
CA991640A (en) 1976-06-22
US3932400A (en) 1976-01-13
NL179733C (nl) 1986-11-03
FR2196162A1 (OSRAM) 1974-03-15
GB1435139A (en) 1976-05-12
DE2341753A1 (de) 1974-02-21
DK149893C (da) 1987-04-21
DE2341753C2 (de) 1982-12-09
FR2196162B1 (OSRAM) 1977-01-28
NL7311248A (OSRAM) 1974-02-19
ZA741280B (en) 1975-03-26
NL179733B (nl) 1986-06-02
CH581640A5 (OSRAM) 1976-11-15
AU5928173A (en) 1975-02-20
DK149893B (da) 1986-10-20

Similar Documents

Publication Publication Date Title
SE7614680L (sv) Sett att framstella nya bensodiazepinderivat
SE417204B (sv) Sett att framstella nya kinoxalin- och kinazolinderivat
SE421615B (sv) Sett att framstella nya tiazolderivat
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE411349B (sv) Sett att framstella nya penicilliner
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE417982B (sv) Sett att framstella cefalosporinforeningar
SE421690B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE397830B (sv) Sett att framstella nya bensodioxol-piperazinderivat
FI55029C (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva isoindolinderivat
SE399255B (sv) Sett att framstella kinazolinonderivat
SE386164B (sv) Sett att framstella nya 2-alkylamino-dihydropyridiner
SE7603276L (sv) Sett att framstella prostansyraderivat
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE420087B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE381257B (sv) Sett att framstella rifamycinderivat
SE400078B (sv) Sett att framstella kinazolinonderivat
SE405966B (sv) Sett att framstella peptider
SE415564B (sv) Sett att framstella nya cefalosporinderivat
SE413022B (sv) Sett att framstella nya propylendiaminderivat
SE384208B (sv) Sett att framstella nya 2,6-diamino-dihydropyridiner
SE400281B (sv) Sett att framstella kinazolinonderivat
SE7610170L (sv) Sett att framstella nya aminoimidazol-isokinolinderivat
FI55198B (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva isoindolinderivat